BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV Trademark
Trademark Overview
On Tuesday, March 5, 2024, a trademark application was filed for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV with the United States Patent and Trademark Office. The USPTO has given the BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV trademark a serial number of 98433740. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 5, 2024. This trademark is owned by TG Therapeutics, Inc.. The BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing health information
General Information
Serial Number | 98433740 |
Word Mark | BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV |
Filing Date | Tuesday, March 5, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Tuesday, March 5, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 0 - NOT AVAILABLE |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Description of Mark | The mark consists of the text "BRIUMVI" above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" with the "B" in "BRIUMVI" partially surrounded by a sphere edged by a circular line; the colors grey and white represent shaded and transparent areas and are not claimed as a feature of the mark. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Providing health information |
NOT AVAILABLE | "150 MG/6ML INJECTION FOR IV" |
Translation of Words in Mark | The wording BRIUMVI has no meaning in a foreign language. |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 5, 2024 |
Primary Code | 044 |
First Use Anywhere Date | Wednesday, December 28, 2022 |
First Use In Commerce Date | Wednesday, December 28, 2022 |
Trademark Owner History
Party Name | TG Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10014 |
Trademark Events
Event Date | Event Description |
Tuesday, March 5, 2024 | NEW APPLICATION ENTERED |